MPWT
ELDN icon

MassMutual Private Wealth & Trust’s Eledon Pharmaceuticals ELDN Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.14K Buy
+1,305
New +$4.75K ﹤0.01% 1667

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CCM
Catalio Capital Management New York $532M AUM 171.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ZP
Zimmer Partners New York $4.34B AUM 22.78% 1-Year Est. Return

MassMutual Private Wealth & Trust's ELDN Position: Q2 2026 in Review

MassMutual Private Wealth & Trust opened a new position in Eledon Pharmaceuticals (ELDN) in Q2 2026: 1,305 shares worth $5.14K. The stake represents ﹤0.01% of the portfolio and ranks #1667 among its holdings.

161 funds tracked by Wall St. Rank hold ELDN as of Q2 2026.

  • MassMutual Private Wealth & Trust held 1,305 shares of Eledon Pharmaceuticals worth $5.14K as of Q2 2026.
  • Eledon Pharmaceuticals was a new MassMutual Private Wealth & Trust position in Q2 2026.
  • Eledon Pharmaceuticals made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1667 holding.
  • 161 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.